Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Colloids and Surfaces. B, Biointerfaces
|
November 13, 2023
Impact of the physical properties of contact lens materials on the discomfort: role of the coefficient of friction
D Costa, V De Matteis, F Treso, et al.
The Ultrasound Journal
|
February 29, 2020
Billing I-AIM: a novel framework for ultrasound billing
Daralee Hughes, Michelle M Corrado, Irene Mynatt, et al.
The American Journal of Gastroenterology
|
May 9, 2023
Previous SARS-CoV-2 Infection Is Not Associated With Increased Celiac Disease Autoimmunity in Children and Adolescents
Michelle M Corrado, Xiaofan Jia, Cristy Geno Rasmussen, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
November 1, 1990
[An atypical case of visceral leishmaniasis]
F Lo Polito, F Sacco, A Omaggio, et al.
Journal of Bodywork and Movement Therapies
|
November 27, 2024
The reliability and concurrent validity of goniometric and visual estimation in participants with unilateral shoulder pain
Amy I Bousquet, Leif E Aronsen, Jenna M Atlas, et al.
JAMA
|
January 24, 1998
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials
S L Preston, G L Drusano, A L Berman, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2000
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin
G L Drusano, S L Preston, M Van Guilder, et al.
Cell Death and Differentiation
|
September 13, 2014
AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1
F Strappazzon, F Nazio, M Corrado, et al.
Cancer Causes & Control : CCC
|
August 31, 2021
Stage of colorectal cancer diagnosis for immigrants: a population-based retrospective cohort study in Ontario, Canada
A K Lofters, E Gatov, H Lu, et al.
Antimicrobial Agents and Chemotherapy
|
May 21, 1998
Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection
S L Preston, G L Drusano, A L Berman, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Colloids and Surfaces. B, Biointerfaces
|
November 13, 2023
Impact of the physical properties of contact lens materials on the discomfort: role of the coefficient of friction
D Costa, V De Matteis, F Treso, et al.
The Ultrasound Journal
|
February 29, 2020
Billing I-AIM: a novel framework for ultrasound billing
Daralee Hughes, Michelle M Corrado, Irene Mynatt, et al.
The American Journal of Gastroenterology
|
May 9, 2023
Previous SARS-CoV-2 Infection Is Not Associated With Increased Celiac Disease Autoimmunity in Children and Adolescents
Michelle M Corrado, Xiaofan Jia, Cristy Geno Rasmussen, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
November 1, 1990
[An atypical case of visceral leishmaniasis]
F Lo Polito, F Sacco, A Omaggio, et al.
Journal of Bodywork and Movement Therapies
|
November 27, 2024
The reliability and concurrent validity of goniometric and visual estimation in participants with unilateral shoulder pain
Amy I Bousquet, Leif E Aronsen, Jenna M Atlas, et al.
JAMA
|
January 24, 1998
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials
S L Preston, G L Drusano, A L Berman, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2000
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin
G L Drusano, S L Preston, M Van Guilder, et al.
Cell Death and Differentiation
|
September 13, 2014
AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1
F Strappazzon, F Nazio, M Corrado, et al.
Cancer Causes & Control : CCC
|
August 31, 2021
Stage of colorectal cancer diagnosis for immigrants: a population-based retrospective cohort study in Ontario, Canada
A K Lofters, E Gatov, H Lu, et al.
Antimicrobial Agents and Chemotherapy
|
May 21, 1998
Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection
S L Preston, G L Drusano, A L Berman, et al.
Page
of 4